ReShape Lifesciences Inc.

NASDAQ: RSLS · Real-Time Price · USD
3.92
0.72 (22.50%)
At close: Aug 14, 2025, 3:59 PM

ReShape Lifesciences Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-8.06 -3.26 -1.55 -7.23
PEG Ratio
0.09 0.03 0.03 0.11
PS Ratio
7.18 4.28 6.36 32.94
PB Ratio
-227.22 5.58 19.53 9.72
P/FCF Ratio
-12.99 -2.19 -3.25 -28.48
P/OCF Ratio
-12.99 -2.19 -3.26 -29.14
OCF/S Ratio
-0.55 -1.95 -1.95 -1.13
Debt / Equity Ratio
-3.82 0.04 0.05 0.01
Quick Ratio
0.43 1.74 0.84 3.72
Current Ratio
0.92 2.73 1.32 4.13
Asset Turnover
1.67 0.81 1.01 0.25
Interest Coverage
n/a n/a -239.63 -33.35
Return on Equity
28.18 -1.71 -12.62 -1.34
Return on Assets
-1.49 -1.07 -4.15 -1.14
Return on Invested Capital
-9.13 -2.1 -6.71 -0.58
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.63 0.64 0.61 0.61
Net Profit Margin
-0.89 -1.31 -4.11 -4.55
Pretax Profit Margin
-0.89 -1.31 -4.15 -4.56
Operating Profit Margin
-0.83 -1.69 -2.41 -2.04
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.83 -1.67 -2.22 -4.46